Author: Bill Snyder
Vanderbilt, GE unite to study colon tumor development
Jan. 31, 2013—Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.
ResearchMatch adds registry for autism disorders
Jan. 31, 2013—ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies.
Pharmacology society honors Limbird’s impact
Jan. 24, 2013—Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Toxicology society honors Guengerich
Jan. 24, 2013—F. Peter (Fred) Guengerich, Ph.D., Stanford Moore Professor of Biochemistry, is the 2013 recipient of the Society of Toxicology Merit Award in recognition of distinguished achievements to toxicology throughout his career.
School for Science and Math students shine in Intel competition
Jan. 24, 2013—Seven seniors in the School for Science and Math at Vanderbilt (SSMV) made it to the semifinalist level in the Intel Science Talent Search 2013.
Genetic testing just one weapon in HIV/AIDS fight
Jan. 24, 2013—Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea.
VKC’s Science Day explores promise of research
Jan. 24, 2013—Recent advances in genetics and understanding how the brain works raise the possibility that intellectual developmental disabilities are treatable and some actually may be reversible.
Awards honor research staff’s critical role in discovery
Jan. 17, 2013—Karen Adkins, R.N., Elizabeth Card, R.N., and Frances Smith-House are the recipients of the 2012 Research Staff Awards at Vanderbilt University Medical Center.
Flu season’s rise highlights crucial role of vaccination
Jan. 17, 2013—While this year’s flu season appears to be slowing down in some parts of the country, we’re not out of the woods yet, caution officials at Vanderbilt University Medical Center.
AstraZeneca, VU collaborate to develop new treatments for major brain disorders
Jan. 14, 2013—AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.
Mouse study sheds light on boy-girl differences
Jan. 10, 2013—There may be a biological basis for separate doll and dump truck aisles in the toy store.
Kennedy Center Science Day set for Jan. 15
Jan. 10, 2013—The latest science relevant to autism, Down syndrome and post-traumatic stress disorder will be discussed Tuesday, Jan. 15, during Science Day 2013, sponsored by the Vanderbilt Kennedy Center for Research on Human Development.
